Analysis:
The question asks: “How many measles cases will be reported in the United States in 2026?” (units: cases for the calendar year 2026). My outside view starts with the 2025 baseline of roughly 2255 cases combined with current reporting from multiple reputable sources. For example, the South Carolina Department of Public Health reported an outbreak with 789 cases as of January 27, 2026 while NBC News and AP report that the CDC has confirmed on the order of 400+ measles cases nationally in early 2026. In contrast, historical trends before the resurgence in 2024 were very low, but 2025 saw an 8‐fold jump over 2024. Current opinions from identifiable experts (e.g., Dr Moffitt at Boston Children’s Hospital and CDC representatives) as well as the structural factors—a decline in MMR vaccination rates (from about 95.2% down to 92.5% for kindergartners), loss of endemic elimination status in parts of the Americas, and multiple interconnected outbreaks—all strongly support the continuation of a high transmission trend into 2026.

(a) Source analysis:
• South Carolina DPH (updated January 27, 2026) reports 789 outbreak cases in one county; these are factual counts of a local outbreak.
• NBC News (January 23/27, 2026) and AP provide nationwide figures (e.g., 416 cases confirmed so far in 2026) and background statistics from 2025 including 2255 cases and about 49 outbreaks; these are reputable and based on CDC data.
• PAHO and Astho report the loss of elimination status and note that 2025 saw record measles activity; these are authoritative.
For each source, factual data (case counts, outbreak numbers, vaccination percentages) is clearly separated from expert opinions urging concern due to declining vaccination. Overall, the sources are highly credible with recent publication dates.

(b) Evidence analysis:
● Strong evidence: Multiple independent sources document large outbreaks in 2025 and persistent community transmission in early 2026. Declining vaccination coverage (below the herd immunity threshold) and the loss of elimination status are structural, hard-to-change factors.
● Moderate evidence: The early 2026 count (e.g., 206 cases reported in one week per NBC) suggests high immediate momentum; however, outbreak dynamics and public health responses may cause deceleration.
● Weak evidence: Anecdotal reports of vaccine hesitancy or single localized outbreak data offer minor adjustments relative to the overall trend.

(c) Timeframe analysis:
The prediction window is from January 1, 2026 to December 31, 2026. Today is January 27, 2026, so about 11 full months remain. If the effective transmission period were halved (e.g., rapid public health containment) the total might be closer to the 2500–2800 range; if it were doubled (with widespread and sustained outbreaks) total cases might approach the upper bound near 4200–4800. Given current momentum and the seasonality of measles (with peaks in late winter/spring), the middle scenario (moderate continuation) appears most plausible.

(d) Justification:
Key factors shifting my outside view—from a 2025 baseline of roughly 2255 cases—to a higher count in 2026 include:
1. The early 2026 data (e.g., 206 cases in one week and strong local outbreaks such as South Carolina’s 789 cases) indicates that transmission remains vigorous.
2. Structural issues such as persistently low vaccination coverage and active community transmission continue to fuel outbreaks.
3. Although some public health campaigns may eventually slow the progression, the current trajectory and historical trend (an 8‐fold jump from 2024 to 2025) imply that 2026 will be worse, though hopefully not catastrophically above 5000 as the hint constrains.
I view the reference class for 2026 entirely as an extension of the current outbreak regime; hence my inside view prediction shifts the base rate upward moderately.

Probability calibration:
If the current momentum continues but public health efforts yield modest mitigation, I expect the 2026 total to be on the order of 3000–4000 cases. In my distribution, the median (P50–P60) is around 3500–3600 cases. The lower tail (P1/P5) corresponds to an optimistic scenario where containment is very effective (lower bound near 2200) and the upper tail (P90/P95/P99) reflects high sustained transmission (but still under the 5000 bound).

Checklist:
1. Target variable: Total measles cases (unit: cases) in the United States for the calendar year 2026.
2. Base rate: 2255 cases in 2025; shifted upward given January 2026 momentum.
3. Consistency check: Implied median is ~3500; mean is near 3600. This is consistent with strong current outbreaks.
4. Top pieces of evidence:
   - Persistence and momentum of multiple outbreaks (e.g., South Carolina’s large outbreak).
   - Declining vaccination coverage (below 95% threshold).
   - Recent 2025 record (2255 cases) with an upward trend.
5. Blind-spot statement: A scenario where public health interventions are exceptionally effective (e.g., mass vaccination campaigns) could push the final count toward the lower end, near 2200–2400 cases.

Distribution:
Percentile 1: 2200  
Percentile 5: 2400  
Percentile 10: 2500  
Percentile 20: 2800  
Percentile 40: 3200  
Percentile 60: 3600  
Percentile 80: 4000  
Percentile 90: 4200  
Percentile 95: 4400  
Percentile 99: 4800